Author: Durai, Prasannavenkatesh; Batool, Maria; Shah, Masaud; Choi, Sangdun
Title: Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control Cord-id: g198m8rr Document date: 2015_8_28
ID: g198m8rr
Snippet: Middle East respiratory syndrome coronavirus (MERS-CoV) causes high fever, cough, acute respiratory tract infection and multiorgan dysfunction that may eventually lead to the death of the infected individuals. MERS-CoV is thought to be transmitted to humans through dromedary camels. The occurrence of the virus was first reported in the Middle East and it subsequently spread to several parts of the world. Since 2012, about 1368 infections, including ~487 deaths, have been reported worldwide. Nota
Document: Middle East respiratory syndrome coronavirus (MERS-CoV) causes high fever, cough, acute respiratory tract infection and multiorgan dysfunction that may eventually lead to the death of the infected individuals. MERS-CoV is thought to be transmitted to humans through dromedary camels. The occurrence of the virus was first reported in the Middle East and it subsequently spread to several parts of the world. Since 2012, about 1368 infections, including ~487 deaths, have been reported worldwide. Notably, the recent human-to-human ‘superspreading' of MERS-CoV in hospitals in South Korea has raised a major global health concern. The fatality rate in MERS-CoV infection is four times higher compared with that of the closely related severe acute respiratory syndrome coronavirus infection. Currently, no drug has been clinically approved to control MERS-CoV infection. In this study, we highlight the potential drug targets that can be used to develop anti-MERS-CoV therapeutics.
Search related documents:
Co phrase search for related documents- accessory nonstructural and acute sars cov respiratory syndrome coronavirus: 1, 2
- accessory nonstructural structural and acute sars cov respiratory syndrome coronavirus: 1
- accessory protein and acid inducible gene: 1
- accessory protein and acid inducible gene retinoic: 1
- accessory protein and active site: 1, 2
- accessory protein and acute pneumonia: 1
- accessory protein and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- accessory structural and active site: 1, 2
- accessory structural and acute pneumonia: 1, 2
- accessory structural and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- accessory structural protein and active site: 1, 2
- accessory structural protein and acute sars cov respiratory syndrome coronavirus: 1, 2
- acid inducible gene and activate immune response: 1, 2
- acid inducible gene and active site: 1
- acid inducible gene and acute pneumonia: 1
- acid inducible gene and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acid inducible gene retinoic and active site: 1
- acid inducible gene retinoic and acute pneumonia: 1
- acid inducible gene retinoic and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
Co phrase search for related documents, hyperlinks ordered by date